ACORDA THERAPEUTICS (ACOR) UP MOVE IS AN OPPORTUNITY

Acorda Therapeutics (ACOR) is up due to the positive opinion on Marketing Authorization Application for its MS drug Ampyra in Europe.  This approval for Acorda Therapeutics was expected.  The big move in Acorda is unwarranted.  We are short selling in the strength now with an average price $32.98 and will add if the

Read More

LIMITED BRANDS (LTD) BOUNCE IS AN OPPORTUNITY TO SELL

Limited Brands (LTD) reported earnings after the close.   The earnings were below the whisper number.   The projections  of  Limited Brands was  less than the published consensus and quite a bit below the whisper numbers. The growth of Limited Brands is clearly slowing.   Bounce in the stock is

Read More

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

Skip to content